EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of HIV infected children with indinavir, zidovudine and lamivudine Two-year follow-up



Treatment of HIV infected children with indinavir, zidovudine and lamivudine Two-year follow-up



AIDS (Hagerstown) 14(Supplement 4): S81, October




(PDF 0-2 workdays service: $29.90)

Accession: 035980456

Download citation: RISBibTeXText



Related references

Dutch multicenter trial on the treatment of HIV infected children with indinavir, zidovudine and lamivudine 1 year follow-up. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 522, 1999

Treatment of HIV infected children with highly antiretroviral therapy consisting of indinavir, zidovudine and lamivudine 3-Year follow-up. International Journal of Antimicrobial Agents 17(Supplement 1): S104, June, 2001

A two-year follow-up of zidovudine plus lamivudine combined with indinavir in antivival naive HIV-infected patients. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 74(2): 128-133, 2000

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. Aids 17(16): 2345-2349, 2003

Dutch multicenter trial on the treatment of HIV infected children with zidovudine, indinavir and lamivudine. AIDS (London) 12(SUPPL 4): S92, 1998

Indinavir, zidovudine, lamivudine: 3-year follow-up. Annals of Internal Medicine 134(2): 165-165, 2001

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA 285(9): 1155-1163, 2001

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II). Aids 14(11): 1601-1610, 2000

AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. Aids 14(4): 367-374, 2000

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. New England Journal of Medicine 341(25): 1865-1873, 1999

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine. Journal of Infectious Diseases 183(7): 1116-1120, 2001

An open-label, randomized, comparative study of stavudine + lamivudine + indinavir versus zidovudine + 3TC + IDV in treatment of HIV-infected patients START I. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 471, 1999

Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir. Journal of Acquired Immune Deficiency Syndromes 31(5): 464-471, 2002

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Annals of Internal Medicine 133(1): 35-39, 2000